Impact of COVID-19 on Outcomes of Patients Hospitalized with STEMI: A Nationwide Propensity-Matched Analysis.
INTRODUCTION: Patients with ST-segment elevation myocardial infarction (STEMI) and concurrent coronavirus disease 2019 (COVID-19) have been reported to have poor outcomes. However, previous studies are small and limited.
METHODS: The National Inpatient Sample (NIS) database for the year 2020 was queried to identify all adult hospitalizations with a primary diagnosis of STEMI, with and without concurrent COVID-19. A 1:1 propensity score matching was performed.
RESULTS: A total of 159,890 hospitalizations with a primary diagnosis of STEMI were identified. Of these, 2,210 (1.38%) had concurrent COVID-19. After propensity matching, STEMI patients with concurrent COVID-19 had a significantly higher mortality (17.8% vs 9.1%, OR 1.96, p
CONCLUSION: STEMI patients with concurrent COVID-19 infection had a significantly higher (almost two times) in-hospital mortality, and lower likelihood of receiving same-day PCI, overall (any-day) PCI, and CABG during their admission, compared with STEMI patients without COVID-19.
Published In/Presented At
Goel, A., Malik, A. H., Bandyopadhyay, D., Isath, A., Gupta, R., Hajra, A., Shrivastav, R., Virani, S. S., Fonarow, G. C., Lavie, C. J., & Naidu, S. S. (2022). Impact of COVID-19 on Outcomes of Patients Hospitalized with STEMI: A Nationwide Propensity-Matched Analysis. Current problems in cardiology, 101547. Advance online publication. https://doi.org/10.1016/j.cpcardiol.2022.101547
Medicine and Health Sciences
Department of Medicine, Cardiology Division